LCLei Cai

Lei Cai

*This is an algorithmically generated author record based on publicly available information.

Lei Cai has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Jing He

    College of Medical Technology, Chengdu University of Traditional Chinese Medicine, Chengdu, 611103, China; Chongqing Key Laboratory of Sichuan-Chongqing Co-construction for Diagnosis and Treatment of Infectious Diseases Integrated Traditional Chinese and Western Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, 611130, China

    1 shared publication
  • Kehui Ouyang

    College of Animal Science and Technology, Jiangxi Agricultural University, Nanchang 330045, China

    1 shared publication
  • Lingli Chen

    College of Food Science and Engineering, JiangXi Agricultural University, Nanchang 330045, China

    1 shared publication
  • Wenjun Wang

    College of Food Science and Engineering, JiangXi Agricultural University, Nanchang 330045, China

    1 shared publication
  • Yang Zhang

    College of Food Science and Engineering Jiangxi Agricultural University Nanchang P.R. China

    1 shared publication
  • Yantian Tang

    Heyuan Branch, Guangdong Laboratory for Lingnan Modern Agriculture, Heyuan 517000, China

    1 shared publication

Latest Publications

  • Open Access

    Chimonanthus nitens Oliv Polysaccharides Modulate Immunity and Gut Microbiota in Immunocompromised Mice

    by Yang Zhang, Yantian Tang, Lei Cai, Jing He, Lingli Chen, Kehui Ouyang, Wenjun Wang

    To investigate the immunomodulatory activities of Chimonanthus nitens Oliv polysaccharides (COP1), an immunosuppressive mouse model was generated by cyclophosphamide (CY) administration and then treated with COP1. The results demonstrated that COP1 ameliorated the body weight and immune organ (spleen and thymus) index of mice and improved the pathological changes of the spleen and ileum induced by CY. COP1 strongly stimulated the production of inflammatory cytokines (IL-10, IL-12, IL-17, IL-1β, and TNF-α) of the spleen and ileum by promoting the mRNA expressions. Furthermore, COP1 had immunomodulatory activity by increasing several transcription factors (JNK, ERK, and P38) in the mitogen-activated protein kinase (MAPK) signaling pathway. Related to the above immune stimulatory effects, COP1 positively affected the production of short-chain fatty acids (SCFAs) and the expression of ileum tight junction (TJ) protein (ZO-1, Occludin-1, and Claudin-1), upregulated the level of secretory immunoglobulin A (SIgA) in the ileum and microbiota diversity and composition, and improved intestinal barrier function. This study suggests that COP1 may provide an alternative strategy for alleviating chemotherapy-induced immunosuppression.